Advanced Biomed (ADVB) Change in Accured Expenses (2024 - 2026)

Advanced Biomed has disclosed Change in Accured Expenses across 3 years of filings, most recently posting $40345.0 for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $40345.0, up 101.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (up 188.67% YoY), and the FY2025 annual result was -$117661.0, down 124.53% from the prior year.
• Change in Accured Expenses came in at $40345.0 for Q1 2026 at Advanced Biomed, up from -$99499.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $2.1 million in Q2 2025 to a low of -$2.2 million in Q1 2025.
• The 3-year median for Change in Accured Expenses is -$82467.0 (2024), against an average of -$34196.7.
• Peak annual rise in Change in Accured Expenses reached 1016.43% in 2025, while the deepest fall reached 2584.6% in 2025.
• Advanced Biomed's Change in Accured Expenses stood at -$132706.0 in 2024, then grew by 25.02% to -$99499.0 in 2025, then soared by 140.55% to $40345.0 in 2026.
• The last three Change in Accured Expenses figures came in at $40345.0 (Q1 2026), -$99499.0 (Q4 2025), and -$232574.0 (Q3 2025), per Business Quant data.